Dankos Farma is a finished-dose manufacturer based in Indonesia. It appears in 123 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with BPOM (ID), NPRA (MY) and NAFDAC (NG). Its GMP standing is certified by BPOM (ID) and NAFDAC (NG). Customs aggregates show $29K of exports covering 2 molecules to 2 destinations in 2025.
| Site | FDA FEI |
|---|---|
| -, Indonesia | Not on file |
| KODYA JAKARTA TIMUR, Indonesia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| BPOM (ID) | 117 | 32 |
| NPRA (MY) | 5 | None |
| NAFDAC (NG) | 1 | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $29K | 2 |
| 2024 | Not reported | $340K | 4 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Dankos Farma comes back tiered against every other supplier able to file there.
Start for free